U.S. Software Stock News

If you are wondering whether RH's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are saying about the stock's value today. RH shares last closed at US$128.37, after returns of a 9.7% decline over 7 days, a 35.8% decline over 30 days, a 33.6% decline year to date, a 43.0% decline over 1 year, a 47.9% decline over 3 years and a 75.1% decline over 5 years. Recent coverage around RH has focused on how the company is positioned...

Donaldson Company (NYSE:DCI) has agreed to acquire Facet, a provider of filtration solutions for aerospace, defense, and power generation. The deal is intended to expand Donaldson's product lineup and deepen its presence in durable end markets tied to critical infrastructure and equipment. The acquisition adds exposure to customers that require highly technical filtration in mission critical applications. Donaldson Company focuses on filtration technologies across industrial, engine, and...

Wondering if Dell Technologies at around US$151.62 is still fairly priced, starting to look expensive, or offering value? This article is designed to help you frame that question clearly. The stock has seen strong momentum recently, with returns of 3.5% over 7 days, 22.1% over 30 days, 18.6% year to date, 61.4% over 1 year and 332.1% over 3 years. That naturally raises questions about what is already priced in. Recent coverage has focused on Dell as a key name in large scale computing and...

If you are wondering whether Blue Owl Capital's share price now reflects good value or just fresh risks, you are not alone. This article is here to unpack that question clearly. Over the short term the stock has seen sharp moves, with a 7 day return of an 11.5% decline, a 30 day return of a 30.6% decline and a year to date return of a 42.8% decline, while the 1 year return sits at a 51.8% decline compared to a 6.4% gain over 5 years and a 1.9% decline over 3 years. Recent headlines around...

Butler National (BUKS) has reported Q3 2026 revenue of US$26.9 million and basic EPS of US$0.10, set against trailing twelve month revenue of US$91.9 million and EPS of US$0.30 that came with 44.1% earnings growth and a 21.4% net margin over the past year. The company has seen quarterly revenue move from US$21.2 million in Q3 2025 to US$26.9 million in Q3 2026 and basic EPS from US$0.05 to US$0.10 across the same periods, with trailing net income reaching US$19.7 million, which positions the...

In recent weeks, Vital Farms reported weaker-than-expected quarterly earnings, prompting multiple law firms to launch securities investigations while the stock touched a new 52-week low and sector-wide pressures weighed on sentiment. Amid these legal probes and analyst concerns, Director Karl Khoury’s purchase of 5,000 additional shares stands out as a contrasting insider confidence signal. We’ll now examine how the earnings disappointment and resulting legal investigations might reshape...

In early March 2026, Tenaya Therapeutics reported a narrower full-year 2025 net loss of US$90.6 million and highlighted new preclinical data for TN-301 in Duchenne muscular dystrophy alongside a research collaboration with Alnylam Pharmaceuticals on up to 15 cardiovascular gene targets that could yield as much as US$1.13 billion in milestones. Together, these updates underscore how Tenaya is pairing emerging HDAC6 science in DMD and heart failure with a genetically guided partnership model...

Capricor Therapeutics (CAPR) has just posted its FY 2025 first half results with total revenue of US$0 million and a basic EPS loss of US$1.10, while trailing twelve month revenue sits at US$13.39 million with a basic EPS loss of US$1.66. Over recent periods, the company has reported revenue of US$8.88 million and US$13.39 million across the two halves of FY 2024, alongside basic EPS losses of US$0.66 and US$0.51. This provides context for how current margins remain under pressure. With...

Why Hess Midstream (HESM) is back on investor radars Hess Midstream (HESM) is drawing fresh attention after its board authorized a new buyback plan, and the partnership signed a repurchase agreement with JPMorgan to retire up to US$42 million of Class A shares. See our latest analysis for Hess Midstream. At a share price of US$38.99, Hess Midstream has recorded a 7.12% 1 month share price return and 11.94% 3 month share price return. Its 5 year total shareholder return of 166.77% contrasts...

Constellium (NYSE:CSTM) has announced a new share repurchase program of up to $300 million, authorized through the end of 2028. The new program replaces the previous buyback authorization. Constellium intends to use some repurchased shares to settle employee equity obligations, aiming to limit future dilution for shareholders. Constellium, trading at $24.61, has laid out a fresh $300 million buyback plan that directly addresses dilution, which many shareholders watch closely. The stock has...

Orchestra BioMed Holdings (OBIO) just posted a sharp step up in activity for FY 2025, with fourth quarter revenue at US$30.9 million and basic EPS of US$0.10, compared with a full year where trailing twelve month revenue sat at US$33.5 million and EPS on that basis was a loss of US$1.11. The company has seen revenue move from quarterly levels below US$1 million through most of the year to the current US$30.9 million print, while quarterly basic EPS shifted from losses between US$0.49 and...

If you have been wondering whether Universal Display's current share price reflects its true worth, you are not alone. This article aims to unpack that question clearly. The stock last closed at US$94.07, and returns of a 3.1% decline over 7 days, a 28.8% decline over 30 days, and a 22.8% decline year to date, as well as a 36.6% decline over 1 year, a 31.9% decline over 3 years, and a 57.2% decline over 5 years, may have reset expectations and risk perceptions for many investors. Recent news...

Northwest Bancshares (NasdaqGS:NWBI) President and CEO Louis J. Torchio recently acquired additional company shares, increasing his personal stake. The insider purchase took place around the time the bank reported strong fourth quarter financial results. The quarter featured earnings and revenue that were ahead of prior expectations, alongside the insider buying activity. Northwest Bancshares is a regional financial institution focused on community banking services, including deposits,...

USA Compression Partners (NYSE:USAC) has agreed to acquire J-W Power, expanding its contract compression fleet and specialty manufacturing capabilities. The deal is positioned around asset repricing opportunities and deeper participation in compression equipment manufacturing. Management is framing the combination as a way to serve rising demand tied to LNG infrastructure and power needs from AI focused data centers. Industry capacity remains tight, with longer lead times for new compression...

AC Immune (NasdaqGM:ACIU) just posted third quarter FY 2025 revenue of CHF 0.9 million and a basic EPS loss of CHF 0.16, with quarterly net income excluding extra items at a loss of CHF 15.9 million. Over recent periods the company has seen revenue move between CHF 0.7 million and CHF 25.5 million per quarter, while EPS has ranged from a loss of around CHF 0.23 per share to a modest profit of CHF 0.06 per share, which underscores how sensitive results can be to revenue timing. For investors,...

Here Group (NasdaqGM:HERE) has just reported Q2 2026 results that mark a sharp reset in the top line, with revenue at C¥127.1 million and a basic EPS loss of C¥0.49, while the trailing 12 month figures still reflect a net profit margin of 12.3%. Over recent quarters the company has seen revenue move from C¥1,000.1 million in Q4 2024 to C¥810.4 million in Q1 2025, then to C¥726.6 million in Q2 2025, C¥570.7 million in Q3 2025 and C¥617.8 million in Q4 2025. Over the same period, basic EPS...

Eastman Kodak (KODK) just closed out FY 2025 with Q4 revenue of US$290 million and a basic EPS loss of US$0.85, capping a year in which trailing 12 month revenue was US$1.07 billion and EPS loss reached US$1.47. Over recent quarters, revenue has moved from US$247 million in Q1 2025 to US$290 million in Q4, while quarterly basic EPS ranged from a loss of US$0.12 to a wider loss of US$0.85 as margins came under pressure. With the stock trading at US$6.97, this set of results focuses attention...

Angel Studios FY 2025 Results: Revenue Growth Meets Persistent Losses Angel Studios (ANGX) has reported new figures for FY 2025, with third quarter revenue at about US$76.5 million and a basic EPS loss of US$0.25. Over the trailing twelve months, revenue stands at roughly US$242.7 million and the basic EPS loss at US$3.54. The company’s quarterly revenue has moved from US$20.1 million in Q3 2024 to US$31.0 million in Q4 2024, then to US$47.4 million in Q1 2025, US$87.6 million in Q2 2025 and...

If you are wondering whether Transocean shares still offer value after a strong run, this article will walk through what the current price could mean for long term investors. The stock last closed at US$6.36, with returns of 7.3% over the past week, 6.0% over the past month, 50.0% year to date, and 109.2% over the past year. This naturally raises questions about how much of the story is already reflected in the price. Recent headlines around Transocean have focused on its position in the...

Lennar (LEN) has kicked off its Q1 2026 reporting cycle with investors watching how its recent revenue and EPS trends set the tone for the year, after posting Q4 2025 revenue of US$9.4b and basic EPS of US$1.93, alongside Q3 2025 revenue of US$8.8b and EPS of US$2.29. Over the last few quarters, the company has seen revenue move from US$9.9b and EPS of US$4.06 in Q4 2024 to US$7.6b and EPS of US$1.96 in Q1 2025. This gives investors a clear run of numbers to weigh against a trailing net...

Transcontinental Realty Investors (TCI) has wrapped up FY 2025 with fourth quarter revenue of US$12.1 million and basic EPS of US$0.96, alongside trailing 12 month EPS of US$1.60 on revenue of US$49.1 million. This lines up with a 135.5% earnings uplift and a net profit margin of 28.1%. Over recent quarters, revenue has been relatively steady in a US$11.7 million to US$12.8 million range, while basic EPS has moved from US$0.01 in Q4 2024 to US$0.96 in Q4 2025. This has taken place against a...

American Public Education (APEI) closed FY 2025 with Q4 revenue of US$158.3 million and basic EPS of US$0.70, alongside trailing twelve month revenue of US$648.9 million and EPS of US$1.40, setting a clear earnings season marker for investors. The company reported a decline in quarterly revenue from US$164.1 million in Q4 2024 to US$158.3 million in Q4 2025, while basic EPS increased from US$0.65 to US$0.70 over the same period, and those figures now sit against trailing twelve month net...

VEON (NasdaqGS:VEON) has just reported new figures for FY 2025, with Q3 revenue of US$1.1 billion, a basic EPS loss of US$2, and a net income loss of US$131 million, setting the tone for how the year is shaping up. The company’s quarterly revenue has moved from US$998 million in Q4 2024 to US$1.1 billion in Q3 2025. Over the same period, basic EPS shifted from about US$1.14 in Q4 2024 to US$8.5 in Q2 2025 and then to a loss of US$2 in Q3 2025, leaving investors focused on how the reported...

Illumina (NasdaqGS:ILMN) and Nashville Biosciences have expanded the Alliance for Genomic Discovery by adding Regeneron Genetics Center as a member. The alliance is launching a new multiomic dataset initiative that includes 312,000 whole genomes and 50,000 paired whole genome and proteomic samples. The effort involves major pharmaceutical firms, including GSK, Amgen and now Regeneron, to support large scale drug discovery and clinical research across diverse diseases. For investors watching...